---
title: "Occlutech to launch atrial septal defect occluder in the USA"
date: "2024-01-15T16:53:43.000Z"
publishedDate: "15 janvier 2024"
summary: "Occlutech has announced that the US Food and Drug Administration (FDA) has approved the Occlutech ASD Occluder and Occlutech Pistol Pusher for the treatment of atrial septal defects (ASD). With this approval, Occlutech will immediately begin commercialisation in an exclusive partnership with distributor B Braun Interventional Systems Inc."
importance: ""
sourceUrl: "https://cardiovascularnews.com/occlutech-to-launch-atrial-septal-defect-occluder-in-the-usa/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-01-15-occlutech-to-launch-atrial-septal-defect-occluder-in-the-usa"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2017/04/Occlutech-logo-fi.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/occlutech-to-launch-atrial-septal-defect-occluder-in-the-usa/"
---

![Occlutech to launch atrial septal defect occluder in the USA](https://cardiovascularnews.com/wp-content/uploads/sites/14/2017/04/Occlutech-logo-fi.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/occlutech-to-launch-atrial-septal-defect-occluder-in-the-usa/*

## L’essentiel

Occlutech has announced that the US Food and Drug Administration (FDA) has approved the Occlutech ASD Occluder and Occlutech Pistol Pusher for the treatment of atrial septal defects (ASD). With this approval, Occlutech will immediately begin commercialisation in an exclusive partnership with distributor B Braun Interventional Systems Inc.

## Lien source

https://cardiovascularnews.com/occlutech-to-launch-atrial-septal-defect-occluder-in-the-usa/
